Latest News- Erectile Dysfunction (ED) Drugs Market: Hospital pharmacy is expected to lead the End-user segment during 2025-2029

The Erectile Dysfunction (ED) Drugs Market is being driven by Rising demand for ED drugs

The Erectile Dysfunction (ED) Drugs Market is expected to grow at a CAGR of 6.6% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 1503 million. The ED drugs market is presently dominated by oral formulations, which account for a significant market share. However, the landscape is poised for disruption with the emergence of novel formulations, including topical gels, injectables, and suppositories, during the forecast period. These innovative treatments offer distinct therapeutic advantages and are anticipated to attract a substantial patient base. One such promising novel formulation is Eroxon, a nitroglycerin gel by Futura Medical, currently undergoing Phase III clinical trials for ED treatment. In the Phase II study, Eroxon demonstrated notable improvements in ED symptoms and a favorable safety profile, positioning it as a potential game-changer in the ED therapeutics industry. 

Get more information on Erectile Dysfunction (ED) Drugs Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• End-user
  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy
• Product
  • Oral drugs
  • Topical drugs
  • Others
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
  • Asia
    • China
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Rising demand for ED drugs
• Rising awareness of ED
• High prevalence of conditions resulting in ED

However, the market also witnesses some limitations, which are as follows:

• Availability of generics
• Side-effects of available drugs
• Poor reimbursement scenario

Benefits of Buying Global Erectile Dysfunction (ED) Drugs Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Erectile Dysfunction (ED) Drugs Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Erectile Dysfunction (ED) Drugs market is driven by various factors including sedentary lifestyle, stress, chronic diseases such as diabetes, heart disease, and hypertension, comorbidities from smoking, excessive drinking, and recreational drug use. ED is linked to sexual intercourse and erection, which can be affected by food, alcohol, and drug absorption. Sildenafil, Tadalafil, Vardenafil, Avanafil, and other ED medications like Viagra are popular treatments. Psychological disorders such as depression and anxiety also contribute to ED. Promotional campaigns and awareness initiatives play a role in increasing market growth. Obesity is another significant factor influencing the demand for ED drugs.

Market Research Overview

The global pharmaceuticals market encompasses entities involved in the research and development (R&D) or production of various drug categories, including generic and non-generic medicines, as well as veterinary drugs. According to Technavio, the healthcare market size is determined by the consolidated revenue generated by manufacturers and providers of medical equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Factors driving the expansion of the pharmaceuticals market include the growing elderly population, with the proportion of individuals aged 60 years and above projected to rise significantly in both the US and Europe by 2030-2050, as well as the increasing prevalence of chronic conditions such as sedentary lifestyle, stress, diabetes, heart disease, type 2 diabetes mellitus, smoking, excessive drinking, and recreational drug use.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/